US asset manager
Legg Mason is a US investment management firm with a focus on asset management and serves customers worldwide.
Legg Mason serves individual and institutional investors on six continents and has $7446bn in AUM (as of 30 June 2018). It uses a multi-manager business model, with each of the company's subsidiaries operating independently.
The company offers products in equities and fixed income, as well as domestic and international liquidity management and alternative investments. Created in 1970 through the acquisition of Mason & Co by Legg & Co to form Legg Mason & Co, it has since become the 20th largest asset manager in the world. Among its brands is Edinburgh-based equity specialist Martin Currie.
Spent 20 years at JPMAM
Newly established team
Over the past year, global bond markets have been buffeted by a storm of political and macro headlines: the pace and timing of US Federal Reserve rate hikes; Brexit; China slowdown concerns; Italian referendum; oil markets and key elections in Europe...
Risk of Abe resigning
Left Legg Mason last year after 35 years
Inflation to reach 2% by 2018
Top-ten funds from Bestinvest
'Focus on growth, not value'
Was head of UK sales at Legg Mason
The Japanese stockmarket had been sluggish and trading-orientated in the wake of the yen's recent appreciation, partly reflecting renewed jitters over the Trump risk when it came to the US presidential election, writes Hideo Shiozumi, manager of the Legg...
New objective and introduction of use of derivatives
GDP growth has been sluggish, so there has been a premium for companies that have improved margins in the US, expanded their business, spun off non-performing assets or segments, cut costs, etc, while still operating at a high level.
To head up London, South West and family offices
Key announcements over the break
Fund launched last month
Moves to Melbourne with family
Tilney Bestinvest reveals best-selling funds
For subsidiary RARE
Helped by new Abenomic reforms
Tom Ormrod joins firm
M&G latest to launch new service
First onshore product from RARE
Healthcare was one sector that did not fully participate in the recent stockmarket rally and finished the first quarter as the worst performer in the S&P 500 index, writes Legg Mason's Evan Bauman.
Follows withdrawal of majority stakeholder